Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Regenet

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Pancreas|April 10, 2014
Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric studyPierre-Emmanuel Robert, Christophe Leux, Mehdi Ouaissi, et al.
Annals of Surgery|September 28, 2017
Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter StudyJean Robert Delpero, Florence Jeune, Philippe Bachellier, et al.
United European Gastroenterology Journal|July 20, 2018
Risk factors and outcomes of infected pancreatic necrosis: Retrospective cohort of 148 patients admitted to the ICU for acute pancreatitisCharlotte Garret, Matthieu Péron, Jean Reignier, et al.
Surgery|November 22, 2015
Is the 2-cm size cutoff relevant for small nonfunctioning pancreatic neuroendocrine tumors: A French multicenter studyNicolas Regenet, Nicolas Carrere, Guillaume Boulanger, et al.
BJS Open|October 25, 2024
Influence of pancreatic fistula on survival after upfront pancreatoduodenectomy for pancreatic ductal adenocarcinoma: multicentre retrospective studyFanny Castanet, Jeanne Dembinski, Bastien Cabarrou, et al.
Annals of Surgery|July 25, 2022
Effect of the Use of Reinforced Stapling on the Occurrence of Pancreatic Fistula After Distal Pancreatectomy: Results of the REPLAY (REinforcement of the Pancreas in distaL pAncreatectomY) Multicenter Randomized Clinical TrialAude Merdrignac, Jonathan Garnier, Safi Dokmak, et al.
Annals of Surgical Oncology|August 15, 2015
Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric CohortDaniel Pietrasz, Lysiane Marthey, Mathilde Wagner, et al.
Annals of Surgical Oncology|October 27, 2018
How Does Chemoradiotherapy Following Induction FOLFIRINOX Improve the Results in Resected Borderline or Locally Advanced Pancreatic Adenocarcinoma? An AGEO-FRENCH Multicentric CohortDaniel Pietrasz, Olivier Turrini, Véronique Vendrely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2025
Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study)Lilian Schwarz, Jean-Baptiste Bachet, Aurelia Meurisse, et al.
Annals of Surgical Oncology|July 25, 2019
Watch and Wait Approach for Re-excision After Unplanned Yet Macroscopically Complete Excision of Extremity and Superficial Truncal Soft Tissue Sarcoma is Safe and Does Not Affect Metastatic Risk or Amputation RateGauthier Decanter, Eberhard Stoeckle, Charles Honore, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Pancreas|April 10, 2014
Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric studyPierre-Emmanuel Robert, Christophe Leux, Mehdi Ouaissi, et al.
Annals of Surgery|September 28, 2017
Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter StudyJean Robert Delpero, Florence Jeune, Philippe Bachellier, et al.
United European Gastroenterology Journal|July 20, 2018
Risk factors and outcomes of infected pancreatic necrosis: Retrospective cohort of 148 patients admitted to the ICU for acute pancreatitisCharlotte Garret, Matthieu Péron, Jean Reignier, et al.
Surgery|November 22, 2015
Is the 2-cm size cutoff relevant for small nonfunctioning pancreatic neuroendocrine tumors: A French multicenter studyNicolas Regenet, Nicolas Carrere, Guillaume Boulanger, et al.
BJS Open|October 25, 2024
Influence of pancreatic fistula on survival after upfront pancreatoduodenectomy for pancreatic ductal adenocarcinoma: multicentre retrospective studyFanny Castanet, Jeanne Dembinski, Bastien Cabarrou, et al.
Annals of Surgery|July 25, 2022
Effect of the Use of Reinforced Stapling on the Occurrence of Pancreatic Fistula After Distal Pancreatectomy: Results of the REPLAY (REinforcement of the Pancreas in distaL pAncreatectomY) Multicenter Randomized Clinical TrialAude Merdrignac, Jonathan Garnier, Safi Dokmak, et al.
Annals of Surgical Oncology|August 15, 2015
Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric CohortDaniel Pietrasz, Lysiane Marthey, Mathilde Wagner, et al.
Annals of Surgical Oncology|October 27, 2018
How Does Chemoradiotherapy Following Induction FOLFIRINOX Improve the Results in Resected Borderline or Locally Advanced Pancreatic Adenocarcinoma? An AGEO-FRENCH Multicentric CohortDaniel Pietrasz, Olivier Turrini, Véronique Vendrely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2025
Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study)Lilian Schwarz, Jean-Baptiste Bachet, Aurelia Meurisse, et al.
Annals of Surgical Oncology|July 25, 2019
Watch and Wait Approach for Re-excision After Unplanned Yet Macroscopically Complete Excision of Extremity and Superficial Truncal Soft Tissue Sarcoma is Safe and Does Not Affect Metastatic Risk or Amputation RateGauthier Decanter, Eberhard Stoeckle, Charles Honore, et al.
Pageof 7